These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31586772)

  • 41. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
    JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
    Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C
    Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
    Lincoff AM; Tardif JC; Schwartz GG; Nicholls SJ; Rydén L; Neal B; Malmberg K; Wedel H; Buse JB; Henry RR; Weichert A; Cannata R; Svensson A; Volz D; Grobbee DE;
    JAMA; 2014 Apr; 311(15):1515-25. PubMed ID: 24682069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.
    Jain R; Mahableshwarkar AR; Jacobsen PL; Chen Y; Thase ME
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):313-21. PubMed ID: 22963932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial.
    Davidson KW; Bigger JT; Burg MM; Carney RM; Chaplin WF; Czajkowski S; Dornelas E; Duer-Hefele J; Frasure-Smith N; Freedland KE; Haas DC; Jaffe AS; Ladapo JA; Lespérance F; Medina V; Newman JD; Osorio GA; Parsons F; Schwartz JE; Shaffer JA; Shapiro PA; Sheps DS; Vaccarino V; Whang W; Ye S
    JAMA Intern Med; 2013 Jun; 173(11):997-1004. PubMed ID: 23471421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlates and Escitalopram Treatment Effects on Sleep Disturbance in Patients with Acute Coronary Syndrome: K-DEPACS and EsDEPACS.
    Kim JM; Stewart R; Bae KY; Kang HJ; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    Sleep; 2015 Jul; 38(7):1105-11. PubMed ID: 25581916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
    Furey ML; Drevets WC
    Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modifying effects of depression on the association between BDNF methylation and prognosis of acute coronary syndrome.
    Kim JM; Stewart R; Kim JW; Kang HJ; Lee JY; Kim SY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    Brain Behav Immun; 2019 Oct; 81():422-429. PubMed ID: 31255678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome.
    Kim SW; Kang HJ; Bae KY; Shin IS; Hong YJ; Ahn YK; Jeong MH; Berk M; Yoon JS; Kim JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):250-254. PubMed ID: 28689006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Incidence and risk factors of depression after a first coronary acute syndrome: A prospective study among 110 patients].
    Ben Halima G; Cherif W; Ben Aoun M; Cherif F; Gueddiche F; Ben Slima H; Mourali MS; Ben Ameur Y; Sdiri W; Cheour M; Damak R
    Ann Cardiol Angeiol (Paris); 2020 May; 69(3):125-132. PubMed ID: 32331696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. External validity of randomized clinical trial studying preventing depressive symptoms following acute coronary syndrome.
    Madsen MT; Juel K; Simonsen E; Gögenur I; Zwisler ADO
    Brain Behav; 2021 Aug; 11(8):e02132. PubMed ID: 34145796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for depression and anxiety among patients with acute coronary syndrome in acute care settings: a scoping review.
    Marin TS; Walsh S; May N; Jones M; Gray R; Muir-Cochrane E; Clark RA
    JBI Evid Synth; 2020 Sep; 18(9):1932-1969. PubMed ID: 32813429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent versus new-onset depressive symptoms: Relationships with biomarkers of cardiovascular health following acute coronary syndrome.
    Madva EN; Celano CM; Smith DM; Januzzi JL; Huffman JC
    J Psychosom Res; 2021 Jan; 140():110291. PubMed ID: 33227557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial.
    Hansen MV; Madsen MT; Hageman I; Rasmussen LS; Bokmand S; Rosenberg J; Gögenur I
    BMJ Open; 2012; 2(1):e000647. PubMed ID: 22240653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial.
    Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    Clin Psychopharmacol Neurosci; 2017 May; 15(2):126-131. PubMed ID: 28449559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation and symptoms of depression and anxiety in patients with acute coronary heart disease.
    Steptoe A; Wikman A; Molloy GJ; Messerli-Bürgy N; Kaski JC
    Brain Behav Immun; 2013 Jul; 31():183-8. PubMed ID: 22982340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequential Combination of Cognitive-Behavioral Treatment and Well-Being Therapy in Depressed Patients with Acute Coronary Syndromes: A Randomized Controlled Trial (TREATED-ACS Study).
    Rafanelli C; Gostoli S; Buzzichelli S; Guidi J; Sirri L; Gallo P; Marzola E; Bergerone S; De Ferrari GM; Roncuzzi R; Di Pasquale G; Abbate-Daga G; Fava GA
    Psychother Psychosom; 2020; 89(6):345-356. PubMed ID: 32791501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anxiety and clinical outcomes of patients with acute coronary syndrome: a meta-analysis.
    Li J; Ji F; Song J; Gao X; Jiang D; Chen G; Chen S; Lin X; Zhuo C
    BMJ Open; 2020 Jul; 10(7):e034135. PubMed ID: 32647021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.